BloodCenter of Wisconsin’s Diagnostic Laboratories, part of Versiti, today announced the launch of seven hematology genetics test panels. The new test panels enhance and expand BloodCenter’s genetic testing capability to include a vast array of non-malignant hematology disorders, including platelet function disorders, inherited thrombocytopenia and congenital neutropenias, providing one of the most comprehensive test menus in hematology.
BloodCenter’s integration of functional and genetic testing provides a unique approach to diagnosing complex hematology disorders, providing a comprehensive review of each patient for improved patient care and outcomes.
To view the multimedia release go to:
https://www.multivu.com/players/English/8126851-bloodcenter-of-wisconsin-versiti-hematology-genetics-test-panels/
Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, commemorated its 50-year anniversary by awarding $150,000 in total grants to three organizations that share its goal to improve healthcare: The American Red Cross, the National Ovarian Cancer Coalition and Autism Speaks.
At a ceremony at the company’s flagship clinical laboratory in Teterboro, NJ, the company’s chairman, president and CEO Steve Rusckowski presented Health In Your Hands grants of $50,000 to representatives from each organization. Paul Brown, M.D., founder and former CEO of Quest’s predecessor company Metropolitan Pathology Laboratory, Inc. or MetPath, established in April, 1967, was also recognized at the event.
To view the multimedia release go to:
https://www.multivu.com/players/English/8080751-quest-diagnostics-50th-anniversary/
Roche (SIX: RO, ROG; OTCQX: RHHBY) launched its presence at the American Association for Clinical Chemistry (AACC) 2016 Clinical Lab Expo today by featuring several next-generation diagnostic testing platforms and a new virtual reality experience that gives attendees an “under the hood” look at a lab of the future and an innovative concept Roche calls the “Roche connected lab.”
The virtual reality theater will enable attendees to view samples moving through a virtual lab equipped with various configurations of Roche automation, chemistry/immunoassay platforms and molecular diagnostics systems, as well as connections to third-party platforms. The actual Roche systems that are part of the connected lab concept will also be on display in the booth.
To view the multimedia release go to:
http://www.multivu.com/players/English/7889151-roche-aacc-2016/
Combining their expertise in clinical trials support and cellular therapies, BloodCenter of Wisconsin (BCW) and the San Diego Blood Bank (SDBB) have created a strategic partnership to accelerate advancements in research and patient care. Together, BloodCenter of Wisconsin and San Diego Blood Bank will offer Celluvative™ – a portfolio of products and clinical trial services that will include esoteric laboratory testing, blood products for research and manufacturing applications, cell processing, and access to a broad database of diverse donors who have expressed interest in clinical trials.
“Through the strength of our partnership, we are able to offer end-to-end services to academic organizations, research institutions and other industry partners who are working to develop novel cellular therapy approaches,” said Matthew Anderson, M.D., Ph.D., medical director, BloodCenter of Wisconsin Diagnostic Laboratories. “Among other offerings, our Celluvative portfolio enables access to an extremely diverse donor database – an invaluable resource to enable advances in the area of regenerative medicine and drug discovery.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7855451-bloodcenter-sdbb-celluvative/
BloodCenter of Wisconsin’s Diagnostic Laboratories today announced the availability of a comprehensive cancer mutation HemeOnc Panel using next generation sequencing (NGS) technology. The NGS panel developed by BloodCenter of Wisconsin is designed to detect variants in 30 genes that are either prognostic or diagnostic for 10 different myeloid hematologic malignancies.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7363151-bloodcenter-of-wisconsin-launches-next-generation-sequencing-hemeonc-panel/
Abbott and the United States Department of Defense today announced a collaboration with the intent to develop portable blood tests to help evaluate potential concussions, also called mild traumatic brain injuries (TBIs). As part of a multi–phased approach, the tests would be developed for Abbott’s i–STAT® System, a handheld, diagnostic analyzer that is currently used for other point-of-care testing, including among military service members. Concussions are a significant health concern for military service members.1 With the development of new tests, physicians could use the information to positively impact the care of people with a suspected concussion.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7293951-abbott-u-s-department-of-defense-develop-portable-blood-tests-concussions/
With the introduction of Abbott's iDesign Dx system, U.S. ophthalmologists now have a diagnostic tool that can capture five optical measurements in one three-second scan to determine the patient's visual abnormalities. This highly advanced diagnostic tool measures the internal optics and surface of the eye more precisely than conventional methods, allowing doctors to fully evaluate imperfections that result in poor vision. Obtaining these measurements in one three-second scan enables ophthalmologists to screen patients more efficiently to determine if they are eligible for LASIK or other refractive surgery and to assist in diagnosis of other conditions.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64467-abbott-idesign-dx-system-available-for-opthalmologists-and-patients
http://www.obd2express.co.uk/wholesale/multi-diag-truck-heavy-duty-diagnostic-tool-bluetooth.html
MULTI-DI@G TRCUK Heavy Duty Diagnostic tool is developed by European companies. It covers all European trucks, buses and light vehicles, the DTCs and data is absolutely accurate, ad michell and alldata, multi-diag truck includes maintenance information, manual, circuit diagram and device parameters.
In recognition of Melanoma Monday® and National Melanoma/Skin Cancer Detection & Prevention MonthTM, MELA Sciences, Inc. (NASDAQ: MELA) visited the NASDAQ MarketSite in Times Square today to ring the Opening Bell and sponsor free skin cancer checks.
One American dies every hour from melanoma, the most deadly skin cancer. MELA Sciences, Inc. is the pioneer company behind MelaFind®, the first and only FDA-approved diagnostic tool that helps dermatologists detect melanoma at its most curable stage. MelaFind® was approved by the U.S. Food & Drug Administration (FDA) in Fall 2011, and since then has strategically rolled out the technology to dermatology practices across the country.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61584-mela-sciences-rings-opening-bell-awareness-melanoma-detection-prevention
Website SEO Competitive Analysis Reports at www.clicktecs.com - Webscan generates detailed online competitive analysis reports to analyze competitors and devise a foolproof SEO strategy. Our online website analysis reports show camparision on various traffic and ranking related aspects like On Page SEO Factors such as Title Tags, Meta Tags, website internal linking structure. It also shows Off Page SEO Factors such as quality backlinks, and Social Signals like facebook fans, social media presence, and a technology audit that includes W3C coding check etc.
Webscan is a comprehensive Website Diagnostic Tool. With over 40 individual tests from website speed, broken links, twitter mention, metadata and many more. To know more and run an online competitor analysis report for your website contact us at www.clicktecs.com
An information technology degree from Kaplan University could be the first step towards a potential information technology career.* Earning an IT degree online can seem like a daunting task, but Kaplan University faculty and staff are available to students through email, instant messaging, and phone calls as well as weekly online seminars.
Kaplan University students who have completed their online information technology degrees have gone on to work at major corporations including Microsoft and Ticketmaster. The IT degree program offered by Kaplan University presents students with real-world scenarios and offers the support to learn in an interactive environment. Constant communication and extensive resources positions Kaplan University among the top online universities.
Completing a university degree online allows the student to continue working full time while being able to take classes that fit into their busy schedules. Even in a difficult economy, a degree from Kaplan University is an investment in your future. Technological advances are not slowing down and those who can manage information technology and all that an IT degree encompasses could have a relevant career ahead of them.
* Kaplan University's programs are designed to prepare graduates to pursue employment in their field of study, or in related fields. However, the University does not guarantee that graduates will be placed in any particular job, eligible for job advancement opportunities, or employed at all. Additional training or certification may be required.
“The Information Systems and Technology programs at Kaplan [University] are very real-world and very relevant. Kaplan [University] teaches its students skills that are really necessary in today’s work place. One of the things we do for an incoming student at Kaplan [University] is we provide them very early on with some diagnostic testing that helps them identify not only their academic strengths and opportunities for learning, but also helps them identify their areas of interest and their strengths outside of the academic setting. From the first day the student virtually steps on to the campus they’re empowered to be successful.
Every day our faculty talk with students and help them think about how they can accomplish what they need to accomplish in order to be successful at school. They want to make sure that the students are comfortable in their environment and students will tell you that they can get a hold of anybody just about any time.
All of the faculty members have instant messaging and email capabilities and they have office hours where you can contact them or you can email them and they’ll always get back to you.
I have well over 300 students on my messenger list so there’s still a lot of that personalization and we try to get in there and really help the students succeed.
The support I got from my teachers and advisors was tremendous. They were caring and they seemed like they were really interested in what was going on.
We’re very serious about our work so that our students are learning and growing and when they graduate they’re prepared for what they’re doing. In the classroom we’re relaxed and we talk to each other.
I was very surprised; I actually met a lot of wonderful people online and I’ve made lifelong friends with them.
We have a seminar every week online where you meet with the instructor and all the students; it’s like a chat room. It involves an audio feature so they can hear the instructor speak. It allows for much more interactive questioning and dialogue so the student gets much more out of the seminar experience. We want to connect talent to success, to career and job success.
Now, with my education, I’ll be able to make better money which means better opportunities for my kids, my family and a better quality of life. The quality of education that I received at Kaplan University was superb. It was far beyond anything I could have imagined.
One of my former students has al
Rules-Based Medicine, Inc. (RBM), today announced the widespread commercial availability of VeriPsych™, the first and only blood-based diagnostic test to aid in confirming the diagnosis of recent onset schizophrenia, a potentially devastating and costly mental illness that affects about 24 million people worldwide. VeriPsych is an innovative molecular diagnostic tool designed to complement the healthcare provider’s clinical impression.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/rulesbasedmedicine/46237/
